Search

Displaying results 4001 - 4010 of 10000 in total
  1. Drug

    Mifamurtide

    go.drugbank.com/drugs/DB13615
    ApprovedInvestigational

    As a liposomal formulation, mifamurtide demonstrates an enhanced tumoricidal effect and improved safety profile [A31745]. Mifamurtide is marketed in Europe as Mepact for intravenous infusion. … Also called L-MTP-PE, mifamurtide may be a liposomal form of of the active ingredient MTP-PE, which is a synthetic, less pyrogenic, and longer-acting derivative of muramyl dipeptide (MDP).

    Products: MEPACT 4 MG INFÜZYONLUK DISPERSIYON KONSANTRESI IÇIN TOZ ,FLAKON, 1 ADET, MEPACT® POLVO PARA CONCENTRADO PARA DISPERSIÓN PARA PERFUSIÓN
  2. Target

    Claudin-6

    go.drugbank.com/bio_entities/BE0013711
    TargetHumans

    Plays a major role in tight junction-specific obliteration of the intercellular space

    Polypeptides: Claudin-6
  3. Indication

    Stage 4 Pancreatic adenocarcinoma

    go.drugbank.com/conditions/DBCOND0025282
    Drugs: Gemcitabine
    Synonyms: Stage 4 Pancreatic adenocarcinoma
  4. Drug

    Pyrantel

    go.drugbank.com/drugs/DB11156
    ApprovedVet approved

    Pyrantel is mainly available in formulations for dogs and cats as the embonate salt, containing a 34.7% pyrantel base [L1900]. … Pyrantel has shown to be effective after a single dose [L1905]. In humans, it is administered as pyrantel pamoate [A32282],[A32283],[L1893],[L1898].

    Mixtures: PAMOATO DE OXANTEL 250 MG/5ML + PAMOATO DE PIRANTEL 250 MG/5 ML SUSPENSIÓN., PAMOATO DE OXANTEL 250 MG/5ML + PAMOATO DE PIRANTEL 250 MG/5 ML SUSPENSIÓN.Categories: Heterocyclic Compounds, 1-Ring
  5. Drug

    Dimethicone

    go.drugbank.com/drugs/DB11074
    ApprovedInvestigational

    It is used in a number of health and beauty products including hair care products such as shampoo, conditioner, leave-in conditioner, and de-tangling products. … Dimethicone is used as a surfactant, antifoaming agent, carminative in various products such as medical devices, food products, and lubricants.

    Mixtures: PANKREOFLAT 170/310 MG GRANÜL (22x2 g poşet), Diabetics Foot Cream 4 ozCategories: Compounds used in a research, industrial, or household setting, Skin Barrier Activity
  6. Drug

    IDN-7314

    go.drugbank.com/drugs/DB18073
    Experimental

    Synonyms: (s)-3-((s)-2-(2-((2,6-difluorophenyl)amino)-2-oxoacetamido)propanamido)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid, L-alaninamide, n-(2,6-difluorophenyl)-2-oxoglycyl-n-((1s)-1-(carboxymethyl)-2-oxo-3-(2,3,5,6-tetrafluorophenoxy)propyl)-
  7. Target

    6-phosphogluconolactonase

    go.drugbank.com/bio_entities/BE0001966
    TargetThermotoga maritima (strain ATCC 43589 / MSB8 / DSM 3109 / JCM 10099)

    Hydrolysis of 6-phosphogluconolactone to 6-phosphogluconate.

    Polypeptides: 6-phosphogluconolactonaseFunction: 6-phosphogluconolactonase activity
  8. Target

    6-phosphogluconolactonase

    go.drugbank.com/bio_entities/BE0003130
    TargetVibrio cholerae serotype O1 (strain ATCC 39315 / El Tor Inaba N16961)

    Hydrolysis of 6-phosphogluconolactone to 6-phosphogluconate.

    Polypeptides: 6-phosphogluconolactonaseFunction: 6-phosphogluconolactonase activity
  9. Drug

    Prilocaine

    go.drugbank.com/drugs/DB00750
    ApprovedInvestigational

    A local anesthetic that is similar pharmacologically to lidocaine. Currently, it is used most often for infiltration anesthesia in dentistry. (From AMA Drug Evaluations Annual, 1992, p165)

    Mixtures: Prilocaine HCl 4% Epineph 1:200000inj, JETEX % 5 KREM, 5 GSynonyms: N-(2-Methylphenyl)-2-(propylamino)propanamide, 2-(Propylamino)-o-propionotoluidide
  10. Drug

    Atomoxetine

    go.drugbank.com/drugs/DB00289
    ApprovedInvestigational

    (NMDA) receptor,[A18263] indicating a role for the glutamatergic system in the pathophysiology of ADHD. … More recently, positron emission tomography (PET) imaging studies in rhesus monkeys have shown that atomoxetine also binds to the serotonin transporter (SERT),[A178111] and blocks the N-methyl-d-aspartate

    Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP2D6 SubstratesProducts: STRATTERA 4 MG/ML ORAL ÇÖZELTI, ATTEX 4 MG/ML ORAL ÇÖZELTİ, 100 ML